← All organizations

Attralus, Inc.

For profit

Also known as: Attralus, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

May 31, 2025

Timeline

No events for the selected filters.

Drugs by trial phase (4 distinct, 8 trials)

Phase 3 (1 own, 0 via acquisition)

i 124-evuzamitide

Phase 2 (1 own, 0 via acquisition)

at-02

Phase 1 (2 own, 0 via acquisition)

Recent trials (10)

NCT06907849CollaboratorPhase 2May 31, 2025
NCT06788535CollaboratorPhase 3Jan 14, 2025
NCT05951049Lead sponsorPhase 2Sep 21, 2023
NCT05951816CollaboratorPhase 1Jul 31, 2023
NCT05635045CollaboratorPhase 2Dec 31, 2022
NCT05521022Lead sponsorPhase 1Sep 1, 2022
NCT05201911Lead sponsorPhase 1Nov 30, 2021
NCT05235269Study directorPhase 2Nov 30, 2021
NCT05235269Lead sponsorPhase 2Nov 30, 2021
NCT05201911Study directorPhase 1Nov 30, 2021

Details

Founded: San Francisco, CA, US
Last known activity: May 31, 2025